Vertex Pharmaceuticals (NASDAQ: VRTX) and AstraZeneca (NASDAQ: AZN), two of the world's leading drugmakers, missed last year's strong market rally. Both finished 2024 slightly in the red. They're ...
We recently compiled a list of the 10 Best GARP Stocks That Pay Dividends. In this article, we are going to take a look at ...
Although the outlook on AI is widely positive, not all equities in the space are poised for success, as several headwinds ...
The stock has fallen 78% from its previous peak, but Wall Street analysts see significant upside from these levels. The ...
BlackRock's strategic acquisitions aim to boost fee rates. Find out why BLK stock remains a growth opportunity with its $11.6 ...
Microsoft (NASDAQ: MSFT) has quickly emerged as a leading player in the generative AI race through internal investments in ...
Early in a new year is the perfect time to assess where you are financially. Start by ensuring you're protected from fraud ...
"Retail has to remember, things go up fast and they go down fast. Take your profits and don't be greedy," an investor from ...
Schrödinger faces financial losses amid investment in experimental drugs. Key 2025 trial results will reveal its future ...
Recent developments in the legal battle over the planned $3.3 billion UnitedHealth Group (NYSE: UHG) acquisition of Amedisys (Nasdaq: AMED) have moved the ...
There are two primary strategies investors use to research stocks: fundamental analysis and technical analysis. "Typically, ...
22h
Broadridge and Verint say they are testing DeepSeek AI for automation and efficiency, while addressing cybersecurity risks in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback